Clincosm LogoSign in Get a demo

Lymphoma, Non-Hodgkin

Showing NaN - NaN of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • +6 more
  • Duarte, California
  • +41 more
Mar 4, 2020

Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Lymphoma, Non-Hodgkin
  • Huntsville, Alabama
  • +17 more
Aug 22, 2019

Lymphoma, Non-Hodgkin Trial in Canada, United States (TAK-659, NKTR-214)

Withdrawn
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +5 more
Jul 10, 2019

Lymphoma, Non-Hodgkin Trial in Worldwide (Inotuzumab ozogamicin, Rituximab, rituximab + gemcitabine)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Inotuzumab ozogamicin
  • +3 more
  • Burbank, California
  • +176 more
Dec 19, 2018

Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Switzerland, United States (IMGN529)

Completed
  • Lymphoma, Non-Hodgkin
  • Chronic Lymphocytic Leukemia
  • Boston, Massachusetts
  • +6 more
Dec 27, 2017

Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

Completed
Has Results
  • Lymphoma, Large-Cell, Anaplastic
  • Lymphoma, Non-Hodgkin
  • brentuximab vedotin
  • Birmingham, Alabama
  • +21 more
Feb 2, 2017

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in France, United States (brentuximab vedotin)

Completed
Has Results
  • Disease, Hodgkin
  • +2 more
  • brentuximab vedotin
  • Birmingham, Alabama
  • +16 more
Dec 7, 2016

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Canada, United States (brentuximab vedotin,

Completed
Has Results
  • Lymphoma, B-Cell
  • +3 more
  • Birmingham, Alabama
  • +33 more
Oct 14, 2016

Tumors, Lymphoma, Non-Hodgkin Trial in Detroit, New York, Philadelphia (PD-0332991)

Completed
Has Results
  • Neoplasms
  • Lymphoma, Non-Hodgkin
  • Detroit, Michigan
  • +3 more
Dec 3, 2015

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Worldwide (SGN-40, , rituximab)

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +65 more
Feb 6, 2015

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in United States (SGN-40)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +13 more
Dec 17, 2014

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in United States (SGN-40, rituximab, gemcitabine)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +8 more
Dec 17, 2014

Lymphoma, Non-Hodgkin, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic Trial in United States (SGN-35)

Completed
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +3 more
Dec 17, 2014

Carcinoma, Renal Cell, Lymphoma, Non-Hodgkin Trial in United States (SGN-75)

Completed
  • Carcinoma, Renal Cell
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +8 more
Dec 17, 2014

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Germany, United States (brentuximab vedotin)

Completed
  • Disease, Hodgkin
  • +2 more
  • brentuximab vedotin
  • Birmingham, Alabama
  • +8 more
Dec 11, 2014

Lymphoma, Non-Hodgkin, Multiple Myeloma, Giant Lymph Node Hyperplasia Trial in United States (CNTO 328)

Completed
  • Lymphoma, Non-Hodgkin
  • +2 more
  • CNTO 328
  • Little Rock, Arkansas
  • +8 more
Jun 30, 2014

Lymphoma, Non-Hodgkin Trial in United States (TRAIL-R1 mAb (TRM-1; HGS-ETR1))

Completed
  • Lymphoma, Non-Hodgkin
  • TRAIL-R1 mAb (TRM-1; HGS-ETR1)
  • Rochester, Minnesota
  • +6 more
Aug 1, 2013

Lymphoma, Non-Hodgkin, HIV Trial in United States (Filgrastim, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • San Francisco, California
  • +6 more
Oct 31, 2012

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in United States (Leuprolide acetate depot (LAD) 11.25 mg 3

Terminated
Has Results
  • Hodgkin Disease
  • +3 more
  • Leuprolide acetate depot (LAD) 11.25 mg 3 Month
  • Matched placebo
  • Saint Louis, Missouri
  • +3 more
Apr 9, 2010

A Study of Patients With AIDS Syndrome

Completed
  • Sarcoma, Kaposi
  • +3 more
    • Menlo Park, California
    • +22 more
    Sep 11, 2008

    Lymphoma, Non-Hodgkin, Tumors Trial in New York (Meaning-Centered Group Psychotherapy, Standard Supportive Group Psychotherapy)

    Completed
    • Lymphoma, Non-Hodgkin
    • Neoplasms
    • Meaning-Centered Group Psychotherapy
    • Standard Supportive Group Psychotherapy
    • New York, New York
      Memorial Sloan-Kettering Institute for Cancer Research
    Aug 16, 2006

    Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)

    Completed
    • Lymphoma, Non-Hodgkin
    • Recombinant Human Interleukin-2 and Rituximab
    • Tucson, Arizona
    • +32 more
    Feb 2, 2006

    Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)

    Completed
    • Lymphoma, Non-Hodgkin
    • Recombinant Human Interleukin-2 and Rituximab
    • Little Rock, Arkansas
    • +64 more
    Feb 2, 2006

    Lymphoma, Non-Hodgkin, HIV Trial in Newark, New York (Mitoxantrone HCl, Etoposide)

    Completed
    • Lymphoma, Non-Hodgkin
    • HIV Infections
    • Newark, New Jersey
    • +2 more
    Jun 23, 2005